Login

New Cement Grinding Center Boosts Development in Northern Morocco | Mohamed Chafiq - CEO of Ciments du Maroc. 00:10:00

Share On Facebook Share On Twitter

Mohamed Chafiq is the CEO of Ciments du Maroc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Science Outreach category from Nature in partnership|Ananya Vasagiri, Analyst,Schematic Ventures
00:10:00
Millennial Gold Corp.: Building a Sustainable, High-Grade Nevada Portfolio
00:10:00
Scaling Up: How to Transition from Deal-by-Deal Equity Raising to Managing a Billion Dollar Multifamily Fund|Chris Powers,Founder,The Fort
00:10:00
Little Quest: Unveiling Diamond Exploration Potential at One-to-One Mining Conference in London
00:10:00
Commerce Resources Achieves Milestone with First Rare Earth Carbonate Production
00:10:00
Valera Rocks Prepares for ASX IPO with Advanced Exploration Projects in NSW and WA
00:10:00
Exploring Innovations, Ethical Ventures, and the Pursuit of Longevity with a Diverse Investor and Advocate | Jim Mellon, CEO, Agronomics Ltd .
00:10:00
When Women Thrive: Addressing Workforce Challenges and Advancing Economic Growth
00:10:00
TECOM Group's Role in Shaping Dubai's Knowledge Economy and Sustainable Growth | Abdulla Belhoul, CEO ,TECOM Group
00:10:00
SanLam's Strong Financial Performance and Confidence in Future Growth | Paul Hanratty, CEO , Sanlam Limited.
00:10:00
Understanding Reaganomics and Neoliberalism|Henry R. Nau,Professor,George Washington University
00:10:00
Exploring the Shift Towards Energy Efficiency and Collective Self-Consumption in Response to the Energy Crisis | Orazio Iacono, CEO, Hera SpA.

© 2026 Nehu